Literature DB >> 15252736

Survival after oesophagectomy for cancer of the oesophagus.

Hubert J Stein1, Burkhard H A von Rahden, J Rüdiger Siewert.   

Abstract

BACKGROUND: Formerly an inevitably fatal disease, oesophageal cancer today has predictable chances for cure.
METHODS: The recent literature and authors' own experiences in the surgical management of oesophageal cancer was reviewed to identify factors associated with improved survival after oesophagectomy.
RESULTS: Currently reported overall 5-year-survival rates are reaching 40% and more in patients who have had an oesophagectomy performed with curative intention. The reasons for improved survival after surgical resection are multifactorial in nature: decreased postoperative mortality and morbidity (due to improved patient selection, surgical technique and perioperative management), the use of tailored surgical strategies (adopted to the histological tumour type, tumour location, stage of disease and the individual patient's risk profile), and multimodality treatment in patients with locally advanced disease.
CONCLUSION: The prognosis of patients who have had oesophagectomy for oesophageal cancer has markedly improved during the past decades. With improved long-term survival after oesophagectomy, postoperative quality of life gains importance as an additional parameter of outcome after oesophageal cancer surgery.

Entities:  

Mesh:

Year:  2004        PMID: 15252736     DOI: 10.1007/s00423-004-0504-9

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  36 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  [Esophageal carcinoma: 2-stage operation for preventing mediastinitis in high risk patients].

Authors:  H J Stein; H Bartels; J R Siewert
Journal:  Chirurg       Date:  2001-08       Impact factor: 0.955

3.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

Review 4.  Barrett's esophagus and Barrett's carcinoma.

Authors:  Burkhard H A von Rahden; Hubert J Stein; Jörg R Siewert
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

5.  Limited resection for early adenocarcinoma in Barrett's esophagus.

Authors:  H J Stein; M Feith; J Mueller; M Werner; J R Siewert
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

6.  Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma.

Authors:  A G De Boer; P I Genovesi; M A Sprangers; J W Van Sandick; H Obertop; J J Van Lanschot
Journal:  Br J Surg       Date:  2000-12       Impact factor: 6.939

Review 7.  Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagus.

Authors:  Johannes Zacherl; Andreas Sendler; Hubert J Stein; Katja Ott; Marcus Feith; Raimund Jakesz; J Rüdiger Siewert; Ulrich Fink
Journal:  World J Surg       Date:  2003-08-28       Impact factor: 3.352

8.  Trans-hiatal oesophagectomy as palliative treatment for carcinoma of the oesophagus.

Authors:  V O Adegboye; M O Obajimi; A O Ogunseyinde; I A Brimmo; A O Adebo
Journal:  East Afr Med J       Date:  2002-06

9.  Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer.

Authors:  H Bartels; H J Stein; J R Siewert
Journal:  Br J Surg       Date:  1998-06       Impact factor: 6.939

10.  Treatment outcomes of resected esophageal cancer.

Authors:  Wayne Hofstetter; Stephen G Swisher; Arlene M Correa; Kenneth Hess; Joe B Putnam; Jaffer A Ajani; Marcelo Dolormente; Rhodette Francisco; Ritsuko R Komaki; Axbal Lara; Faye Martin; David C Rice; Arcenio J Sarabia; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Jack A Roth
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  10 in total

1.  [Neoadjuvant therapy for squamous cell carcinoma of the esophagus].

Authors:  F Lordick
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

2.  Locally advanced esophageal cancer: What becomes of 5-year survivors?

Authors:  Galal Ghaly; Mohamed Kamel; Abu Nasar; Subroto Paul; Paul C Lee; Jeffrey L Port; Paul J Christos; Brendon M Stiles; Nasser K Altorki
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-30       Impact factor: 5.209

Review 3.  The significance of lymph node status as a prognostic factor for esophageal cancer.

Authors:  Yasunori Akutsu; Hisahiro Matsubara
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

4.  Improved long-term survival after esophagectomy for esophageal cancer: influence of epidemiologic shift and neoadjuvant therapy.

Authors:  Frank Makowiec; Peter Baier; Birte Kulemann; Goran Marjanovic; Peter Bronsert; Katja Zirlik; Michael Henke; Ulrich Theodor Hopt; Jens Hoeppner
Journal:  J Gastrointest Surg       Date:  2013-05-02       Impact factor: 3.452

5.  c-myc amplification is frequent in esophageal adenocarcinoma and correlated with the upregulation of VEGF-A expression.

Authors:  Burkhard H A von Rahden; Hubert J Stein; Franziska Pühringer-Oppermann; Mario Sarbia
Journal:  Neoplasia       Date:  2006-09       Impact factor: 5.715

6.  [Esophagectomy as therapeutic principle for squamous cell esophageal cancer].

Authors:  J R Siewert; M Feith; H J Stein
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

7.  Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma.

Authors:  Jianguo Zhang; Xiaojing Yang; Yuchan Wang; Hui Shi; Chengqi Guan; Li Yao; Xianting Huang; Zongmei Ding; Yuejiao Huang; Huijie Wang; Chun Cheng
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

8.  Prognostic factors for the survival of patients with esophageal cancer in Northern Iran.

Authors:  Mahmood Reza Ghadimi; Mahboobeh Rasouli; Mahmood Mahmoodi; Kazem Mohammad
Journal:  J Res Med Sci       Date:  2011-10       Impact factor: 1.852

Review 9.  Endoscopic Therapy of Early Carcinoma of the Oesophagus.

Authors:  Mate Knabe; Andrea May; Christian Ell
Journal:  Viszeralmedizin       Date:  2015-10-19

10.  Recurrence and prognostic model for identifying patients at risk for esophageal cancer after surgery.

Authors:  Dongni Chen; Weidong Wang; Youfang Chen; Jia Hu; Men Yang; Junxian Mo; Zhesheng Wen
Journal:  Cancer Manag Res       Date:  2018-11-21       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.